Wang, Xiao-Dong <br/><br/>
Modifying clopidogrel maintenance doses according to vasodilator-stimulated phosphoprotein phosphorylation index improves clinical outcome in patients with clopidogrel resistance.  [electronic resource] 

 -  Clinical cardiology  May 2011 
 - 332-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-8737 
<br/><br/><label>Standard No.: </label>10.1002/clc.20884  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Angioplasty, Balloon, Coronary--adverse effects<br/>Cardiovascular Diseases--prevention & control<br/>Cell Adhesion Molecules<br/>Clopidogrel<br/>Coronary Angiography<br/>Drug Resistance<br/>Female<br/>Humans<br/>Kaplan-Meier Estimate<br/>Male<br/>Microfilament Proteins<br/>Phosphoproteins<br/>Platelet Aggregation Inhibitors--administration & dosage<br/>Statistics as Topic<br/>Ticlopidine--administration & dosage<br/>Treatment Outcome<br/>Vasodilation--drug effects<br/>Vasodilator-Stimulated Phosphoprotein